← Browse by Condition
Medical Condition

tpo receptor agonists

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06613880 Phase 2
Recruiting

Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia

Enrollment
48 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
View Trial →